Submit Deal

APOTEX INC

Deals Overview

Total Deals6

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Subsidiaries

APOPHARMA INC (DEFERIPRONE BUSINESS)

1 transaction

Senior Management

Jeff Watson
President and CEO
Jack Kay
CEO
Allan Oberman
President and CEO

Sort

arrow pharmaceuticals pty ltd

HQ - Australia

Pharmaceuticals

10 Jul 2019

Investment Date

100%

Stake

n/a

Deal Value

apopharma inc (deferiprone business)

HQ - United States

Health Care Services

13 Jan 2020

Investment Date

100%

Stake

n/a

Deal Value

apotex inc

HQ - Canada

Pharmaceuticals

3 Apr 2023

Investment Date

100%

Stake

n/a

Deal Value

searchlight pharma

HQ - Canada

Pharmaceuticals

3 Jun 2024

Investment Date

100%

Stake

n/a

Deal Value

canprev

HQ - Canada

Pharmaceuticals

3 Feb 2025

Investment Date

100%

Stake

n/a

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy